News
2h
Stocktwits on MSNSarepta Shares Slide To 2017 Lows On Revenue Cut, But Retail Bulls Remain DefiantShares of Sarepta Therapeutics plunged more than 26% on Tuesday, falling to their lowest level since 2017, after the company ...
Super Micro Computer cut its sales outlook for fiscal 2025, citing short-term impacts of heightened economic uncertainty and tariffs that prompted some customers to delay orders. The server maker now ...
Shares of Sarepta Therapeutics fell after the company cut its full-year outlook, citing significant pressures hurting the broader biotech market. The stock tumbled 21%, to $36.75, in after-hours ...
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
Biotech company Sarepta Therapeutics (NASDAQ:SRPT) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with ...
Sarepta Therapeutics shares are sinking after the company releases its first-quarter results after Tuesday's closing bell.
A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...
HubSpot, Inc., the customer platform for scaling businesses, announced today that Kate Bueker, the Company's Chief Financial Officer, is scheduled to present at the JP Morgan Technology Conference in ...
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Tuesday reported a loss of $447.5 million in its first quarter. The Cambridge, Massachusetts-based company said it ...
Intellinetics, Inc. , a digital transformation solutions provider, today announced that it will report its financial results for the first quarter of 2025, the period ended March 31, 2025, on Tuesday, ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...
The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results